Rohde, David http://orcid.org/0000-0002-3785-9375
Vandoorne, Katrien
Lee, I-Hsiu http://orcid.org/0000-0001-7200-7867
Grune, Jana
Zhang, Shuang http://orcid.org/0000-0001-5570-5954
McAlpine, Cameron S.
Schloss, Maximilian J.
Nayar, Ribhu
Courties, Gabriel
Frodermann, Vanessa http://orcid.org/0000-0001-5566-6692
Wojtkiewicz, Gregory http://orcid.org/0000-0002-3148-8411
Honold, Lisa
Chen, Qi http://orcid.org/0000-0001-8485-6540
Schmidt, Stephen
Iwamoto, Yoshiko
Sun, Yuan
Cremer, Sebastian
Hoyer, Friedrich F.
Iborra-Egea, Oriol http://orcid.org/0000-0002-7280-859X
Muñoz-Guijosa, Christian
Ji, Fei
Zhou, Bin http://orcid.org/0000-0001-5278-5522
Adams, Ralf H. http://orcid.org/0000-0003-3031-7677
Wythe, Joshua D.
Hidalgo, Juan http://orcid.org/0000-0003-0921-1122
Watanabe, Hideto
Jung, Yookyung
van der Laan, Anja M.
Piek, Jan J.
Kfoury, Youmna
Désogère, Pauline A.
Vinegoni, Claudio http://orcid.org/0000-0002-9818-3639
Dutta, Partha
Sadreyev, Ruslan I.
Caravan, Peter http://orcid.org/0000-0002-3179-6537
Bayes-Genis, Antoni
Libby, Peter http://orcid.org/0000-0002-1502-502X
Scadden, David T.
Lin, Charles P.
Naxerova, Kamila
Swirski, Filip K. http://orcid.org/0000-0002-3163-9152
Nahrendorf, Matthias http://orcid.org/0000-0002-4021-1887
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL142494)
Article History
Received: 9 June 2021
Accepted: 27 October 2021
First Online: 23 December 2021
Competing interests
: M.N. has received funds or material research support from Alnylam, Biotronik, CSL Behring, GlycoMimetics, GSK, Medtronic, Novartis and Pfizer, as well as consulting fees from Biogen, Gimv, IFM Therapeutics, Molecular Imaging, Sigilon, Lilly and Verseau Therapeutics. The authors declare no competing interests.